The what, when and how of stereotactic ablative body radiotherapy for oligometastatic prostate cancer

被引：0
|
作者：
Dreosti, Marcus [1 ]
机构：
[1] GenesisCare, Adelaide, SA, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
46
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [41] Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer
    Franceschini, Davide
    Teriaca, Maria Ausilia
    Dominici, Luca
    Franzese, Ciro
    Scorsetti, Marta
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7009 - 7031
  • [42] Multi-center assessment of stereotactic body radiotherapy in oligometastatic prostate cancer.
    Finkelstein, Steven E.
    Salenius, Sharon
    Cross, Chaundre K.
    Allison, Ron R.
    Dosoretz, Arie P.
    Shafman, Timothy
    Dosoretz, Daniel E.
    Mantz, Constantine
    Fernandez, Eduardo
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] Stereotactic body radiotherapy for lung oligometastatic prostate cancer: An international retrospective multicenter study
    Roge, Maximilien
    Bowden, Patrick
    Conway, Paul
    Franzese, Ciro
    Scorsetti, Marta
    Seront, Emmanuel
    Blanchard, Pierre
    Terlizzi, Mario
    Khalifa, Jonathan
    Pasquier, Corentin
    Shick, Ulrike
    Siva, Shankar
    Paul, Julie
    Supiot, Stephane
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2025, 52
  • [44] Stereotactic body radiotherapy for oligometastatic prostate cancer recurrence after local treatment.
    Laurent, P. A.
    Martin, E.
    Cousin, F.
    Quivrin, M.
    Bidault, F.
    Mazoyer, F.
    Bertaut, A.
    Crehange, G.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S729 - S730
  • [45] Stereotactic ablative radiation therapy for the treatment of oligometastatic prostate cancer.
    Tran, Phuoc T.
    Moyer, C. Leigh
    Phillips, Ryan
    Radwan, Noura
    Ross, Ashley
    Reyes, Diane K.
    Wright, Jean
    Antonarakis, Emmanuel S.
    Song, Daniel Y.
    Deville, Curtiland
    Walsh, Patrick C.
    DeWeese, Theodore L.
    Carducci, Michael Anthony
    Schaeffer, Edward M.
    Pienta, Kenneth J.
    Eisenberger, Mario A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Stereotactic Body Radiotherapy (SBRT) in oligometastatic gynecological cancer
    Cantarella, M.
    Laliscia, C.
    Coraggio, G.
    Morganti, R.
    Montrone, S.
    Delishaj, D.
    Lombardo, E.
    Fabrini, M. G.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S542 - S542
  • [47] Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences
    Ost, P.
    Jereczek-Fossa, B. A.
    Van As, N.
    Zilli, T.
    Tree, A.
    Henderson, D.
    Orecchia, R.
    Casamassima, F.
    Surgo, A.
    Miralbell, R.
    De Meerleer, G.
    CLINICAL ONCOLOGY, 2016, 28 (09) : E115 - E120
  • [48] STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR OLIGOMETASTATIC PROSTATE CANCER PATIENTS: A SINGLE INSTITUTION EXPERIENCE
    Bruni, Alessio
    Mazzeo, Ercole
    Lanfranchi, Biancaluisa
    Rubino, Laura
    Lamin, Laroussi Mohammed
    Mucciarini, Claudia
    Nicolini, Massimiliano
    Lohr, Frank
    Giacobazzi, Patrizia
    ANTICANCER RESEARCH, 2016, 36 (05) : 2566 - 2567
  • [49] Salvage stereotactic body radiotherapy in oligometastatic gynaecological cancer
    Midulla, M.
    Fodor, A.
    Zerbetto, F.
    Deantoni, C. L.
    Tummineri, R.
    Giannini, L.
    Broggi, S.
    Torrisi, M.
    Ferrario, F.
    Chissotti, C.
    Villa, S. L.
    Mangili, P.
    Fiorino, C.
    Arcangeli, S.
    Di Muzio, N. G.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S685 - S686
  • [50] Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
    Siva, Shankar
    Bressel, Mathias
    Murphy, Declan G.
    Shaw, Mark
    Chander, Sarat
    Violet, John
    Tai, Keen Hun
    Udovicich, Cristian
    Lim, Andrew
    Selbie, Lisa
    Hofman, Michael S.
    Kron, Tomas
    Moon, Daniel
    Goad, Jeremy
    Lawrentschuk, Nathan
    Foroudi, Farshad
    EUROPEAN UROLOGY, 2018, 74 (04) : 455 - 462
12345